Skip to main content
. 2023 Oct 2;133(19):e164918. doi: 10.1172/JCI164918

Table 4. Most common noninfectious adverse events experienced by patients with WHIM during treatment with G-CSF or plerixafor.

graphic file with name jci-133-164918-g094.jpg